Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$77.41M
↑ 26% above average
Average (9y)
$61.55M
Historical baseline
Range
High:$182.17M
Low:$-31.89M
CAGR
+10.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $77.41M | +1912.0% |
| 2023 | $-4.27M | -103.6% |
| 2022 | $119.93M | +71.2% |
| 2021 | $70.04M | +39.7% |
| 2020 | $50.13M | +257.2% |
| 2019 | $-31.89M | -117.5% |
| 2018 | $182.17M | +110.8% |
| 2017 | $86.41M | +149.2% |
| 2016 | $34.68M | +12.4% |
| 2015 | $30.86M | - |